DonaACCoffeySFigtreeG. Translational and emerging clinical applications of metabolomics in cardiovascular disease diagnosis and treatment. Eur J Prev Cardiol. 23: 1578–1589.
2.
PlominRHaworthCMADavisOSP. Common disorders are quantitative traits. Nat Rev Genet2009; 10: 872–878.
3.
Ala-KorpelaM. Critical evaluation of 1H NMR metabonomics of serum as a methodology for disease risk assessment and diagnostics. Clin Chem Lab Med2008; 46: 27–42.
4.
Ala-KorpelaMKangasAJSoininenP. Quantitative high-throughput metabolomics: A new era in epidemiology and genetics. Genome Med2012; 4: 36–36.
5.
WürtzPHavulinnaASSoininenP. Metabolite profiling and cardiovascular event risk: A prospective study of 3 population-based cohorts. Circulation2015; 131: 774–785.
6.
WareJH. The limitations of risk factors as prognostic tools. N Engl J Med2006; 355: 2615–2617.
7.
XiaJBroadhurstDIWilsonM. Translational biomarker discovery in clinical metabolomics: An introductory tutorial. Metabolomics2013; 9: 280–299.
